Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B. Preživetje bolnikov z rakom v Sloveniji 1991-2005. Ljubljana: Onkološki inštitut Ljubljana, Register raka RS, 2009.
Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R. et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730–56.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS. et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 14: 977-1010.
De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A. et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009; 45: 909–30.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D. et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 2014; 15: 23-34.
Howlader N, Noone A, Krapcho M, Grashell J, Neyman N, Altekruse S. et al. SEER cancer statistics review, 1975-2010. Bethseda MD: National Cancer Instiutte, 2013.
Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A. et al. NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010; 49: 725–36.
Roche L, Danieli C, Belot A, Grosclaude P, Bouvier AM, Velten M. et al. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Int J Cancer 2013; 132: 2359–69.
Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol 2010; 39: 598–610.
Percy C, Stanek E 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 242–50.
Primic Zakelj M, Pompe-Kirn V, Šelb-Šemrl J. Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for Slovenia. Radiol Oncol 2001; 35: 243–7.
Žagar T, Zadnik V, Pohar Perme M, Primic Zakelj M. Complete yearly life tables by sex for Slovenia, 1982-2004, and their use in public health. Radiol Oncol 2006; 40: 115–24.
Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004; 40: 2494–501.
23. Brenner H, Gefeller O, Hakulinen T. Period analysis for “up-to-date” cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004; 40: 326–35.
Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Bethesda MD: Technical, and Results Evaluation Section, National Cancer Institut, 1959.
Dickman P, Coviello E, Hills M. Estimating and modelling relative survival. Available April 20, 2015 from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.pauldickman.com/survival/strs.pdf">http://www.pauldickman.com/survival/strs.pdf</ext-link>
Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ. et al. Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 2008; 99(Suppl 1): S2–10.